Related Experiment Video
Updated: Nov 1, 2025

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long non-coding RNAs XIST and MALAT1 hijack the PD-L1 regulatory signaling pathway in breast cancer subtypes
Amany Samir1, Reda Abdel Tawab2, Hend M El Tayebi1
1Molecular Pharmacology Research Group, Department of Pharmacology and Toxicology, German University in Cairo, Cairo 11835, Egypt.
Abstract:
Long non-coding RNAs (lncRNAs) have attracted widespread attention as potential biological and pathological regulators. lncRNAs are involved in several biological processes in cancer. Triple negative breast cancer (TNBC) is characterized by strong heterogeneity and aggressiveness. At present, the implication of microRNAs (miRs) and lncRNAs in immunotherapy has been poorly studied. Nevertheless, the blockade of immune checkpoints, particularly that of the programmed cell-death protein-1/programmed cell-death ligand-1 (PD-L1) axis, is considered as a principle approach in breast cancer (BC) therapy. The present study aimed to investigate the interaction between immune-modulatory upstream signaling pathways of the PD-L1 transcript that could enhance personalized targeted therapy. MDA-MB-231 cells were transfected with miR-182-5p mimics followed by RNA extraction and cDNA synthesis using a reverse transcription kit, and the expression levels of the target genes were assessed by reverse transcription-quantitative PCR. Furthermore, the expression levels of target genes were measured in tissues derived from 41 patients with BC, including patients with luminal BC and TNBC, as well as their adjacent lymph nodes. The results revealed that the expression levels of miR-182-5p, PD-L1 and metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) were upregulated in MDA-MB-231 cells and BC tissues. However, X-inactive specific transcript (XIST) expression was downregulated in cancer tissues and TNBC cells. Following co-transfection of cells with small interfering RNAs specific for each target gene and miR-182-5p antagomirs, the effect of miR-182-5p was abolished in the presence of lncRNAs. Therefore, the results of the present study indicated that although miR-182-5p exhibited an oncogenic effect, XIST exerted a dominant effect on the regulation of the PD-L1 signaling pathway via the inhibition of the oncogenic function of MALAT1.
Insights
Long non-coding RNAs (lncRNAs) and microRNAs (miRs) play roles in triple-negative breast cancer (TNBC) immunotherapy. XIST lncRNA dominates PD-L1 regulation, overriding miR-182-5p
Area of Science:
- Molecular Biology
- Cancer Research
- Immunotherapy
Background:
- Long non-coding RNAs (lncRNAs) and microRNAs (miRs) are implicated in cancer development and progression.
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic options.
- The roles of lncRNAs and miRs in PD-L1 immune checkpoint regulation in breast cancer (BC) remain underexplored.
Purpose of the Study:
- To investigate the interaction between immune-modulatory signaling pathways of the programmed cell-death protein-1/programmed cell-death ligand-1 (PD-L1) transcript.
- To explore the regulatory roles of miR-182-5p, MALAT1, and XIST in PD-L1 expression in breast cancer.
- To identify potential targets for personalized targeted therapy in breast cancer.
Main Methods:
- Transfection of MDA-MB-231 cells with miR-182-5p mimics.
- RNA extraction, cDNA synthesis, and reverse transcription-quantitative PCR (RT-qPCR) to assess gene expression.
- Analysis of miR-182-5p, PD-L1, MALAT1, and XIST expression in BC tissues and adjacent lymph nodes from 41 patients.
- Co-transfection with small interfering RNAs (siRNAs) and miR-182-5p antagomirs to elucidate regulatory interactions.
Main Results:
- miR-182-5p, PD-L1, and MALAT1 were upregulated in MDA-MB-231 cells and BC tissues.
- XIST expression was downregulated in cancer tissues and TNBC cells.
- XIST demonstrated a dominant regulatory effect on the PD-L1 signaling pathway, inhibiting MALAT1's oncogenic function and overriding miR-182-5p's effect.
Conclusions:
- miR-182-5p exhibits an oncogenic effect in breast cancer.
- XIST plays a dominant role in regulating the PD-L1 signaling pathway.
- Understanding these lncRNA-miRNA interactions offers potential for novel therapeutic strategies in breast cancer immunotherapy.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Inheritance of Chromatin Structures
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
MicroRNAs
